NEU 5.81% $13.38 neuren pharmaceuticals limited

Yes that is an important distinction. Whilst we released two...

  1. 1,781 Posts.
    lightbulb Created with Sketch. 215
    Yes that is an important distinction. Whilst we released two sets of positive data in that time Acadia announced a failed trial with Nuplazid and paused all plans to further expand the drug into other indications.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.